Disease | lupus erythematosus |
Symptom | C0020538|hypertension |
Sentences | 12 |
PubMedID- 26087631 | Aim: to study the specific features of the development and course of hypertension in patients with systemic lupus erythematosus (sle). |
PubMedID- 24633036 | Successful use of intensive immunosuppressive therapy for treating simultaneously occurring cerebral lesions and pulmonary arterial hypertension in a patient with systemic lupus erythematosus. |
PubMedID- 24562636 | Disease activity is related to acute response to vasodilator in pulmonary artery hypertension associated with systemic lupus erythematosus. |
PubMedID- 22983159 | To develop a more comprehensive understanding of the clinical and pathological characteristics of pulmonary hypertension associated with systemic lupus erythematosus (ph/sle) in the chinese population, a systematic review of the literature up to 2012 was conducted. |
PubMedID- 23560122 | There were also other conditions such as small kidney, tuberculosis infection, urinary tract obstruction, history of schistosomiasis infection, systemic lupus erythematosus (sle) with hypertension, malaria infection, malignancy with hypertension and traditional african herbal poisoning which were found in the patients. |
PubMedID- 21597395 | Objective: to detect coronary artery disease in asymptomatic patients with systemic lupus erythematosus and scleroderma associated with pulmonary hypertension, and to determine whether it is focal or diffuse ischemia. |
PubMedID- 26401258 | All patients with pulmonary hypertension and a diagnosis of systemic sclerosis, systemic lupus erythematosus, or mixed connective tissue disease who underwent the 6mwt between august 1, 2009, and october 30, 2011, were included (n = 66). |
PubMedID- 22300830 | Objective: to evaluate the occurrence of idiopathic intracranial hypertension (iih) in patients with systemic lupus erythematosus (sle) and to describe the manifestations, treatments and outcomes in these patients. |
PubMedID- 23104392 | Intracranial hypertension associated with systemic lupus erythematosus in a young male patient. |
PubMedID- 22489252 | Tables 2 and 3 summarize the pathology and the key causative mechanisms in pulmonary arterial hypertension due to systemic lupus erythematosus . |
PubMedID- 24134304 | Objectives: to determine whether disease activity verified by laboratorial parameters is associated with a higher frequency of hypertension in patients with systemic lupus erythematosus (sle) without renal impairment and to investigate factors that could influence this hypertension. |
PubMedID- 22841984 | Objectives: to investigate the prevalence and predictors of pulmonary hypertension (ph) in patients with systemic lupus erythematosus (sle) and to validate a diagnostic strategy. |
Page: 1